Stéphanie A. Laversin

A novel spontaneous model of epithelial-mesenchymal transition (EMT) using a primary prostate cancer derived cell line demonstrating distinct stem-like characteristics

Naomi Harner-Foreman, Jayakumar Vadakekolathu, Stéphanie A. Laversin et al. · Scientific Reports · 2017 · 45 citations · Full text

Medicine, Cell Biology, Oncology +17

Development and Characterization of Monoclonal Antibodies Specific for Mouse and Human Fcγ Receptors

Alison L. Tutt, Sonya James, Stéphanie A. Laversin et al. · The Journal of Immunology · 2015 · 41 citations

Life Sciences, Cell Biology, Immunology +17

Prognostic significance of crown-like structures to trastuzumab response in patients with primary invasive HER2 + breast carcinoma

Charles N. Birts, Constantinos Savva, Stéphanie A. Laversin et al. · Scientific Reports · 2022 · 17 citations · Full text

Medicine, Immunology, Oncology +17

A combination of trastuzumab and BAG-1 inhibition synergistically targets HER2 positive breast cancer cells

Emmanouil Papadakis, Natalia Robson, Alison Yeomans et al. · Oncotarget · 2016 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17

The effects of restricted glycolysis on stem-cell like characteristics of breast cancer cells

Arindam Banerjee, Pardis Arvinrad, Matthew Darley et al. · Oncotarget · 2018 · 12 citations · Full text

Medicine, Cell Biology, Oncology +12